From Our Partners
Friday, June 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – April 14, 2013

by Global Biodefense Staff
April 14, 2013

Biodefense News - Headlines of the WeekClose-contact infection reported as China’s H7N9 tally reaches 49 | Lessons not learned: Insider threats in pathogen research | Senator requests NIH consider pricing issues in drug collaborations | CDC fights plague in Uganda with eye on bioterror threat | The fight to end pandemics | Researchers find salmonella to be more resistant than originally thought | The global distribution and burden of dengue | Making vaccine for new H7N9 virus could be a challenge, experts say | New cutting-edge research will lead to safer medical experiments on humans | Hospital preparedness program and Hurricane Sandy | Why chemotherapy that costs $75K in the U.S. costs $2,500 in India | New bird flu strain seen adapting to mammals, humans | U.S. Supreme Court to decide if companies can patent human genes | CDC preparedness funds take hit in proposed 2014 budget

See what we’re reading this week at Global Biodefense on topics like H7N9 influenza deaths in China, CDC preparedness budget, global dengue assessment and more… 

Close-contact infection reported as China’s H7N9 tally reaches 49 (CIDRAP) 

Lessons not learned: Insider threats in pathogen research (Bulletin Atomic Scientists) 

Senator requests NIH consider pricing issues in drug collaborations (FLC Newslink) 

CDC fights plague in Uganda with eye on bioterror threat (NTI GSN) 

The fight to end pandemics (Forbes)

Researchers find salmonella to be more resistant than originally thought (Virginia Tech) 

The global distribution and burden of dengue (Nature)

Making vaccine for new H7N9 virus could be a challenge, experts say (HuffPost Canada) 

New cutting-edge research will lead to safer medical experiments on humans (USD)

Hospital preparedness program and Hurricane Sandy (PHE.gov) 

Why chemotherapy that costs $75K in the U.S. costs $2,500 in India (The Atlantic) 

New bird flu strain seen adapting to mammals, humans (Univ of Wisconsin-Madison)

U.S. Supreme Court to decide if companies can patent human genes (The Guardian) 

CDC preparedness funds take hit in proposed 2014 budget (CIDRAP)

From Our Partners

Related Posts

Biodefense Headlines – 16 June 2022
News Scan

Biodefense Headlines – 16 June 2022

June 16, 2022
Biodefense Headlines – 29 May 2022
News Scan

Biodefense Headlines – 29 May 2022

May 29, 2022
Biodefense Headlines – 4 May 2022
News Scan

Biodefense Headlines – 4 May 2022

May 4, 2022
Biodefense Headlines – 5 April 2022
News Scan

Biodefense Headlines – 5 April 2022

April 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC